Edgewise Therapeutics, Inc.

Edgewise Therapeutics, Inc.verified

EWTX

Price:

$35.43

Market Cap:

$3.32B

Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has completed Phase 1 clinical trial. It develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. Edgewise Therapeutics, Inc. was incorporated in 2017 and is headquartered in Boulder, Colorado.[Read more]

Industry

Biotechnology

IPO Date

2021-03-26

Stock Exchange

NASDAQ

Ticker

EWTX

The Enterprise Value as of November 2024 (TTM) for Edgewise Therapeutics, Inc. (EWTX) is 3.28B

According to Edgewise Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 3.28B. This represents a change of 206.12% compared to the average of 1.07B of the last 4 quarters.

Edgewise Therapeutics, Inc. (EWTX) Historical Enterprise Value (quarterly & annually)

How has EWTX Enterprise Value performed in the past?

The mean historical Enterprise Value of Edgewise Therapeutics, Inc. over the last ten years is 849.71M. The current 3.28B Enterprise Value has changed 38.55% with respect to the historical average. Over the past ten years (40 quarters), EWTX's Enterprise Value was at its highest in in the June 2024 quarter at 1.77B. The Enterprise Value was at its lowest in in the March 2021 quarter at -170340290.00.

Quarterly (TTM)
Annual

Average

849.71M

Median

616.45M

Minimum

131.59M

Maximum

1.53B

Edgewise Therapeutics, Inc. (EWTX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Edgewise Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 368.46%

Maximum Annual Enterprise Value = 1.53B

Minimum Annual Increase = -72.33%

Minimum Annual Enterprise Value = 131.59M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023616.45M368.46%
2022131.59M-72.33%
2021475.58M-68.95%
20201.53B2.59%

Edgewise Therapeutics, Inc. (EWTX) Average Enterprise Value

How has EWTX Enterprise Value performed in the past?

The current Enterprise Value of Edgewise Therapeutics, Inc. (EWTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

407.87M

5-year avg

849.71M

10-year avg

849.71M

Edgewise Therapeutics, Inc. (EWTX) Enterprise Value vs. Peers

How is EWTX’s Enterprise Value compared to its peers?

Edgewise Therapeutics, Inc.’s Enterprise Value is greater than Century Therapeutics, Inc. (121.93M), greater than C4 Therapeutics, Inc. (433.80M), greater than Mineralys Therapeutics, Inc. (636.27M), greater than Cullinan Oncology, Inc. (803.64M), greater than Talaris Therapeutics, Inc. (50.00M), greater than Adicet Bio, Inc. (22.31M), greater than Vor Biopharma Inc. (14.80M), greater than Ikena Oncology, Inc. (44.76M), greater than Design Therapeutics, Inc. (299.25M), greater than Xilio Therapeutics, Inc. (-20556410.00), greater than Eliem Therapeutics, Inc. (119.64M), greater than Werewolf Therapeutics, Inc. (-734072.00), greater than Decibel Therapeutics, Inc. (96.42M), greater than Celcuity Inc. (648.54M), greater than TCR2 Therapeutics Inc. (49.64M), less than Revolution Medicines, Inc. (9.76B), greater than Black Diamond Therapeutics, Inc. (175.93M), greater than Atreca, Inc. (-8620212.00), greater than Passage Bio, Inc. (41.61M),

Build a custom stock screener for Edgewise Therapeutics, Inc. (EWTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Edgewise Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Edgewise Therapeutics, Inc. (EWTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Edgewise Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Edgewise Therapeutics, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Edgewise Therapeutics, Inc. (EWTX)?

What is the 3-year average Enterprise Value for Edgewise Therapeutics, Inc. (EWTX)?

What is the 5-year average Enterprise Value for Edgewise Therapeutics, Inc. (EWTX)?

How does the current Enterprise Value for Edgewise Therapeutics, Inc. (EWTX) compare to its historical average?